This systematic review and meta-analysis aimed to determine whether an MPC algorithm-based artificial pancreas system might be more effective and safe than conventional insulin therapy in terms of the risk of hypoglycemia and maintaining glucose levels within the target range in outpatients with T1D. Here, INS is linked to Hypoglycemia.